Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Aging and chronic inflammation: highlights from a multidisciplinary workshop.
Saavedra D, Añé-Kourí AL, Barzilai N, Caruso C, Cho KH, Fontana L, Franceschi C, Frasca D, Ledón N, Niedernhofer LJ, Pereira K, Robbins PD, Silva A, Suarez GM, Berghe WV, von Zglinicki T, Pawelec G, Lage A. Saavedra D, et al. Among authors: ane kouri al. Immun Ageing. 2023 Jun 8;20(1):25. doi: 10.1186/s12979-023-00352-w. Immun Ageing. 2023. PMID: 37291596 Free PMC article. Review.
Immune, inflammatory and prothrombotic parameters in COVID-19 patients treated with an anti EGFR antibody.
Saavedra D, Añé-Kourí AL, Gregorich EML, Mena J, Lorenzo-Luaces P, Londres HD, Martínez AH, Armada JJ, Sánchez YH, González YZ, Troche M, Medel L, Ramos M, Crombet T. Saavedra D, et al. Among authors: ane kouri al. Immunol Lett. 2022 Dec;251-252:1-8. doi: 10.1016/j.imlet.2022.09.005. Epub 2022 Sep 27. Immunol Lett. 2022. PMID: 36174772 Free PMC article.
Blocking EGFR with nimotuzumab: a novel strategy for COVID-19 treatment.
Londres HD, Armada JJ, Martínez AH, Abdo Cuza AA, Sánchez YH, Rodríguez AG, Figueroa SS, Llanez Gregorich EM, Torres Lahera ML, Peire FG, González TM, González YZ, Añé Kouri AL, Palomo AG, Concepción MT, Pérez LM, Luaces-Alvarez PL, Iglesias DE, Hernández DS, Suzarte MR, Ramos TC. Londres HD, et al. Among authors: ane kouri al. Immunotherapy. 2022 May;14(7):521-530. doi: 10.2217/imt-2022-0027. Epub 2022 Mar 21. Immunotherapy. 2022. PMID: 35306855 Free PMC article. Clinical Trial.
Thymic Polypeptide Fraction Biomodulina T Decreases Exhausted and Terminally Differentiated EMRA T Cells in Advanced Lung Cancer Patients Treated With Platinum-Based Chemotherapy.
Suárez GM, Catalá M, Peña Y, Portela S, Añé-Kourí AL, González A, Lorenzo-Luaces P, Díaz M, Molina MLA, Pereira K, Hernández JC, Ramos R, Reyes MC, Ledón N, Mazorra Z, Crombet T, Lage A, Saavedra D. Suárez GM, et al. Among authors: ane kouri al. Front Oncol. 2022 Jan 27;12:823287. doi: 10.3389/fonc.2022.823287. eCollection 2022. Front Oncol. 2022. PMID: 35155258 Free PMC article.
Nimotuzumab for COVID-19: case series.
Abdo Cuza AA, Ávila JP, Martínez RM, González JJ, Aspuro GP, Gutiérrez Martínez JA, Suzarte MR, Hernández DS, Añé-Kouri AL, Ramos TC. Abdo Cuza AA, et al. Among authors: ane kouri al. Immunotherapy. 2021 Nov 22:10.2217/imt-2021-0269. doi: 10.2217/imt-2021-0269. Online ahead of print. Immunotherapy. 2021. PMID: 34806405 Free PMC article.
An anti-CD6 antibody for the treatment of COVID-19 patients with cytokine-release syndrome: report of three cases.
Filgueira LM, Cervantes JB, Lovelle OA, Herrera C, Figueredo C, Caballero JA, Sánchez N, Berrio J, Lorenzo G, Cepeda M, Ramos M, Saavedra D, Añe-Kouri AL, Mazorra Z, Leon K, Crombet T, Caballero A. Filgueira LM, et al. Among authors: ane kouri al. Immunotherapy. 2021 Mar;13(4):289-295. doi: 10.2217/imt-2020-0235. Epub 2021 Jan 5. Immunotherapy. 2021. PMID: 33397150 Free PMC article.
Associations among cytokines, EGF and lymphocyte subpopulations in patients diagnosed with advanced lung cancer.
Suárez GM, Añé-Kourí AL, González A, Lorenzo-Luaces P, Neninger E, Salomón EE, Cordero L, Catalá M, Ledón N, Pereira K, Sánchez MG, García B, Crombet T, Mazorra Z, Saavedra D, Lage A. Suárez GM, et al. Among authors: ane kouri al. Cancer Immunol Immunother. 2021 Jun;70(6):1735-1743. doi: 10.1007/s00262-020-02823-1. Epub 2021 Jan 2. Cancer Immunol Immunother. 2021. PMID: 33388995 Free PMC article.
An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe COVID-19 elderly patients.
Saavedra D, Añé-Kourí AL, Sánchez N, Filgueira LM, Betancourt J, Herrera C, Manso L, Chávez E, Caballero A, Hidalgo C, Lorenzo G, Cepeda M, Valenzuela C, Ramos M, León K, Mazorra Z, Crombet T. Saavedra D, et al. Among authors: ane kouri al. Immun Ageing. 2020 Nov 14;17(1):34. doi: 10.1186/s12979-020-00207-8. Immun Ageing. 2020. PMID: 33292350 Free PMC article.
11 results